3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Leukemia, Myeloid, Acute
24
Leukemia
22
Myelodysplastic Syndromes
21
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Lymphoma
16
Leukemia, Lymphocytic, Chronic, B-Cell
15
Hodgkin Disease
15
Lymphoma, Non-Hodgkin
13
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
13
Multiple Myeloma
12
Hematologic Neoplasms
9
Primary Myelofibrosis
8
Myeloproliferative Disorders
8
Lymphoma, Mantle-Cell
6
Lymphoma, Large B-Cell, Diffuse
6
Graft vs Host Disease
6
Congenital Abnormalities
6
Lymphoma, Follicular
5
Lymphoma, B-Cell, Marginal Zone
5
Leukemia, Myelomonocytic, Juvenile
5
Leukemia, Myelomonocytic, Chronic
5
Leukemia, Myeloid, Chronic-Phase
5
Leukemia, Myeloid, Accelerated Phase
5
Waldenstrom Macroglobulinemia
4
Lymphoma, T-Cell, Cutaneous
4
Lymphoma, Large-Cell, Immunoblastic
4
Burkitt Lymphoma
4
Blast Crisis
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, T-Cell
3
Interventions
Cyclophosphamide
10
Irinotecan
8
Melphalan
7
Vincristine
6
Temozolomide
6
Doxorubicin
6
Busulfan
6
Topotecan
5
Granulocyte Colony-Stimulating Factor
5
Gemcitabine
5
Ifosfamide
4
Filgrastim
4
Etoposide
4
Albumin-Bound Paclitaxel
4
Trabectedin
3
Sirolimus
3
Nivolumab
3
130-nm albumin-bound paclitaxel
3
pegfilgrastim
2
olaparib
2
fludarabine phosphate
2
fludarabine
2
eribulin
2
cixutumumab
2
abemaciclib
2
X-Rays
2
Radiotherapy, Intensity-Modulated
2
Peripheral Blood Stem Cell Transplantation
2
Magnetic Resonance Spectroscopy
2
Granulocyte-Macrophage Colony-Stimulating Factor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Sarcoma, Ewing
×
thymoglobulin
×
Clear all
NCT02472392
2017-05-09
Ewing/Allo
University of Louisville
Phase 1
Completed
10 enrolled